Access Bio Inc (950130) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.015x

Based on the latest financial reports, Access Bio Inc (950130) has a cash flow conversion efficiency ratio of -0.015x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-9.16 Billion ≈ $-6.21 Million USD) by net assets (₩599.93 Billion ≈ $406.56 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 950130 stock market capitalisation for the company's overall valuation and market capitalisation.

Access Bio Inc - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Access Bio Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Access Bio Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Access Bio Inc ranked by their cash flow conversion efficiency. Explore Access Bio Inc (950130) cash flow quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Wintao Communications Co. Ltd SHE:301139	0.002x
K Wave Media Ltd. NASDAQ:KWM	655.501x
NRX Pharmaceuticals Inc NASDAQ:NRXP	0.112x
Perak Transit Bhd KLSE:0186	-0.003x
GreenMobility A/S CO:GREENM	0.802x
Apollo Minerals Ltd AU:AON	-0.137x
Neontech Co. Ltd KQ:306620	0.108x
JLS Co.Ltd KQ:040420	0.043x

Annual Cash Flow Conversion Efficiency for Access Bio Inc (2012–2024)

The table below shows the annual cash flow conversion efficiency of Access Bio Inc from 2012 to 2024. View 950130 share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩442.28 Million ≈ $299.73K	₩13.54 Million ≈ $9.18K	0.031x	+22410.95%
2023-12-31	₩587.14 Billion ≈ $397.90 Million	₩-80.57 Million ≈ $-54.60K	0.000x	-100.02%
2022-12-31	₩487.74 Million ≈ $330.53K	₩291.33 Million ≈ $197.43K	0.597x	+4.71%
2021-12-31	₩241.75 Million ≈ $163.83K	₩137.90 Million ≈ $93.45K	0.570x	-99.88%
2020-12-31	₩76.95 Million ≈ $52.15K	₩36.72 Billion ≈ $24.89 Million	477.222x	+2498.24%
2019-12-31	₩21.22 Million ≈ $14.38K	₩-422.24 Million ≈ $-286.15K	-19.899x	+88.40%
2018-12-31	₩33.42 Million ≈ $22.65K	₩-5.73 Billion ≈ $-3.88 Million	-171.471x	-29.50%
2017-12-31	₩41.13 Million ≈ $27.87K	₩-5.45 Billion ≈ $-3.69 Million	-132.408x	-298039.61%
2016-12-31	₩47.55 Million ≈ $32.22K	₩2.11 Million ≈ $1.43K	0.044x	+19.26%
2015-12-31	₩76.88 Billion ≈ $52.10 Million	₩2.87 Billion ≈ $1.94 Million	0.037x	+197.03%
2014-12-31	₩68.58 Billion ≈ $46.48 Million	₩-2.63 Billion ≈ $-1.79 Million	-0.038x	-221.48%
2013-12-31	₩50.20 Billion ≈ $34.02 Million	₩1.59 Billion ≈ $1.08 Million	0.032x	-62.82%
2012-12-31	₩21.71 Billion ≈ $14.71 Million	₩1.85 Billion ≈ $1.25 Million	0.085x	--

About Access Bio Inc

KQ:950130 Korea Diagnostics & Research

Market Cap

$58.88 Million

₩86.88 Billion KRW

Market Cap Rank

#21379 Global

#1241 in Korea

Share Price

₩2470.00

Change (1 day)

+0.82%

52-Week Range

₩2020.00 - ₩2570.00

All Time High

₩29950.00